Market Overview

UPDATE: Miller Tabak Downgrade Mead Johnson Nutrition Company to Neutral Post Share Rally

Related MJN
Mead Johnson (MJN) Misses on Q2 Earnings, Beats Revs
PetMed Posts In Line Q1 Earnings, Revenues on Lower Orders

Miller Tabak downgraded Mead Johnson Nutrition Company (NYSE: MJN) from Buy to Neutral and maintained a $76.00 price target.

Miller Tabak commented, "[F]ollowing yesterday's 11.5% rally in the stock, we estimate that MJN is currently trading at 23.0x FY 2013 earnings and 15.0x our FY 2013 EBITDA which we think reflects a full multiple given the company's maturing North American/Europe business which makes up 30% of sales with negligible/negative growth, offset by the EM franchise which constitutes 70% of sales and moderating 6%-7% growth for FY 2013. We continue to think the company should trade at a blended 15.0x FY 2013 EBITDA multiple based on a 17.0x-18.0x multiple for the EM segment and 7.0x-8.0x multiple for the developed markets business which, as shown below, generates our $76.00 price target and our neutral rating."

Mead Johnson Nutrition Company closed at $76.00 on Thursday.

Posted-In: Miller TabakAnalyst Color Downgrades Analyst Ratings

 

Most Popular

Related Articles (MJN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free